Loss of chromosome 16q in lobular carcinoma in situ.
Lobular carcinoma in situ (LCIS) and infiltrating lobular carcinoma may represent different forms of the same disease based on their frequent clinical association and similar histologic features. Patients with LCIS are at increased risk of multicentric and bilateral disease. Thus, LCIS may represent both a precursor to infiltrating lobular carcinoma and a marker of risk for breast cancer. To identify genomic alterations in LCIS, comparative genomic hybridization was performed on 17 cases without concurrent invasive carcinoma. Loss involving chromosome 16q was present in 88% of cases and was the sole detected alteration in 29%. Gain involving 1q was second in frequency, occurring in 41% of tumors, and in all cases was associated with loss of 16q. Other recurrent changes were loss involving 17p (18%), 8p (12%), and 12q24 (12%). E-cadherin immunohistochemistry was performed on all LCIS cases to evaluate the correlation of loss involving 16q22, the site of the E-cadherin gene, and altered protein expression. Most cases with 16q22 loss showed altered E-cadherin expression (12 of 13). These results in LCIS are similar to changes reported in infiltrating lobular cancer, confirming a genetic relationship between them. HUM PATHOL 32:292-296.
Cancer Center, University of California San Francisco, San Francisco, CA 94143-0808, USA.
J E
JE
Etzell
S
S
Devries
K
K
Chew
C
C
Florendo
A
A
Molinaro
B M
BM
Ljung
F M
FM
Waldman
D001943:Breast Neoplasms / Q000235:genetics*; D015820:Cadherins / Q000032:analysis / Q000235:genetics; D002278:Carcinoma in Situ / Q000235:genetics*; D018275:Carcinoma, Lobular / Q000235:genetics*; D002878:Chromosomes, Human, Pair 1; D002881:Chromosomes, Human, Pair 12; D002885:Chromosomes, Human, Pair 16; D002886:Chromosomes, Human, Pair 17; D017353:Gene Deletion; D006801:Humans; D007150:Immunohistochemistry; D009693:Nucleic Acid Hybridization; D016133:Polymerase Chain Reaction
D015820:Cadherins